Chief Financial Officer Thomas Schmidt was permanently appointed in November 2025, having joined Evaxion on an interim basis on November 1, 2024. Mr. Schmidt has more than 30 years of financial management experience from across different industries with more than 25 years of these being based in the life science industry including roles as country Managing Director and country Chief Financial Officer in Roche and Group CFO in Ambu.
